Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest liver disease Stories

2013-05-08 08:29:58

Funding to support clinical development of drug candidates to treat rare liver diseases SAN DIEGO, May 8, 2013 /PRNewswire/ -- Lumena Pharmaceuticals, a company developing oral therapeutics for rare liver diseases, today announced the company has secured $23 million in Series A financing. Investors include Pappas Ventures, RiverVest Venture Partners and Alta Partners. Founded in 2011 by Pappas Ventures, Lumena will primarily use the funding to advance the clinical development of...

2013-04-26 10:38:19

New data from two clinical trials presented today at the International Liver Congress 2013 demonstrate substantial improvements in the detection of both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC) using diagnostic urine tests. HCC is common throughout the world and most often develops as a late complication of chronic viral hepatitis or cirrhosis of any cause. The overall survival rate of HCC is poor and so screening for HCC offers the best hope for early detection,...

Primary Sclerosing Cholangitis Is A Unique Condition
2013-04-22 05:10:49

redOrbit Staff & Wire Reports - Your Universe Online Using DNA genotyping technology, researchers from the Wellcome Trust Sanger Institute have determined that primary sclerosing cholangitis (PSC), a rare autoimmune disease affecting the liver, is a unique condition and not a complication of inflammatory bowel disease (IBD). “Before our study, it was never quite clear whether PSC was a complication of IBD or a distinct disease in its own right. We have proven it to be a unique...

2013-04-18 21:29:37

A certain number of patients hospitalized for cirrhosis complications soon develop a syndrome characterized by acute liver failure and/or the failure of other vital organs (ACLF). This syndrome had no specific diagnostic criteria hitherto. In this prospective study, led by Dr Richard Moreau, INSERM Research Director (Mixed Research Unit 773 “Centre de Recherche biomédicale Bichat-Beaujon”; INSERM/Université Paris Diderot) who is also a practitioner...

2013-04-17 08:29:33

-- Abstract Accepted for Presentation at the International Liver Congress 2013 -- NORCROSS, Ga., April 17, 2013 /PRNewswire/ -- Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that its abstract was accepted by the European Association for the Study of the Liver for presentation on April 27, 2013 at the International Liver Congress to be held in Amsterdam, The Netherlands. The...

2013-04-08 11:59:32

Journal of American College of Surgeons study reports that, despite the risks and the costs, liver transplant may also serve as a model for gene therapy through solid organ transplantation for some patients Patients faced with the diagnosis of a life-threatening liver disease have to consider the seriousness of having a liver transplant, which can be a definitive cure for many acquired and genetic liver diseases.  Among the main considerations are the anxiety of waiting for a donor...

2013-03-14 17:26:28

According to WHO, liver cirrhosis accounts for 1.8% (i.e. 170,000) of all deaths in Europe. In recent years liver cirrhosis has become a serious health threat in some Western European countries such as Ireland and the United Kingdom, where over the last 10 years the associated mortality has increased . The European Association for the Study of the Liver (EASL) urges the UK government to press ahead with its proposed implementation of the minimum unit pricing of alcohol. EASL's most recent...

2013-01-16 04:20:47

ALBANY, New York, January 16, 2013 /PRNewswire/ -- According to the latest market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Liver Diseases Therapeutics Market (Chemotherapy, Anti-Virals, Vaccines, Targeted Therapy and Immunosuppressants) - Global Industry Analysis, Size, Share, Trends and Forecast, 2012 - 2018 [http://www.transparencymarketresearch.com/liver-diseases-therapeutics.html ]", the global liver diseases therapeutics...

2013-01-07 12:27:47

VANCOUVER, British Columbia, Jan. 7, 2013 /PRNewswire/ -- NHV is a company that strives to provide the highest quality of natural products for your pets. If you have a pet, and are astonished by the low-quality food and materials that are sold in your average grocery store, and are looking for something that can greatly improve the health, and overall life of your animal, you may want to look into the products that are offered by NHV as they are all natural and very high in quality. They...

2012-11-10 08:21:34

BOSTON, Nov. 10, 2012 /PRNewswire/ -- Researchers at the University of Missouri determined that cirrhosis was not present in more than one-third of patients who had nonalcoholic fatty liver disease (NAFLD) that led to hepatocellular carcinoma (HCC). The records of 17,785 Medicare patients who had HCC were studied, and it was determined that 16 percent of those patients had NAFLD and no other way of developing cancer. About 64 percent of those patients had nonalcoholic...